Phreesia and Klick coauthored this report, which explores results from two patient surveys conducted earlier this year, to examine LGBTQ+ patients’ own perceptions of preventive care and highlight disparities in LGBTQ+ patients’ knowledge and usage of preventive health services.
Before they can seek preventive care, LGBTQ+ patients first need to understand what it is and why it’s important—and they aren’t always getting those messages. And while LGBTQ+ patients are more likely than others to say that they intend to seek preventive care for conditions that tend to be associated with the LGTBQ+ community—such as HIV—they are far less likely to seek it for conditions such as high blood pressure, high cholesterol or cancer.
And there’s a twin problem looming alongside inequities in preventive care: a lack of representation of and outreach to the LGBTQ+ community that impacts patient trust.
With insights from these surveys, pharma marketers can begin to help close gaps in care and boost representation of this population while remaining sensitive to LGBTQ+ patients’ unique needs.
